N4 Pharma (LON:N4P) Trading 24.8% Higher – Should You Buy?

N4 Pharma Plc (LON:N4P) traded up 24.8% during mid-day trading on Wednesday . The company traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.66 ($0.01). 8,658,934 shares changed hands during trading, an increase of 318% from the average session volume of 2,072,280 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Price Performance

The company has a market capitalization of £2.57 million, a PE ratio of -55.00 and a beta of -0.37. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62. The firm’s 50-day moving average is GBX 0.62 and its 200-day moving average is GBX 0.57.

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.